What Happened?
Redwood City, CA-based Revolution-Medicines Appointed Daniel Simon as Chief Business Officer
About the Company
Revolution Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
About the Person
Daniel Simon is Chief Business Officer at Revolution Medicines. Previously, Daniel held various senior HR leadership roles in the industry.
Info Source
News
Short Profile